KLF2 is a clinical diagnostic and treatment biomarker of breast cancer

Background: As a highly prevalent malignancy among women worldwide, breast cancer, remains a critical public health issue necessitating the development of novel therapeutics and biomarkers. Kruppel Like Factor 2 (KLF2), a member of the Kruppel family of transcription factors, has been implicated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ya-Zhao, Xie, Juan, Wang, Rui-Qi, Gao, Xiao-Qian, Liu, Pei-Jun, Liu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133575/
https://www.ncbi.nlm.nih.gov/pubmed/37123417
http://dx.doi.org/10.3389/fcell.2023.1182123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133575/
https://www.ncbi.nlm.nih.gov/pubmed/37123417
http://dx.doi.org/10.3389/fcell.2023.1182123

Ejemplares similares